Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure

Kinugawa Koichiro; Sato Naoki; Inomata Takayuki; Yasuda Moriyoshi; Shibasaki Yoshiyuki; Shimakawa Toshiyuki

首页> 外文期刊>Circulation journal >Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure

【24h】

Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure

机译：新的风险评分有效地预防洛维坦诱导的心力衰竭患者的高缺失事件

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: It has been 7 years since tolvaptan was approved in Japan for the indication of heart failure in patients with volume overload; the drug can be used in patients with normonatremia. Hypernatremia was identified as a significant adverse event to be prevented.

机译：背景：自托尔瓦坦在日本批准的患者批准患者的患者的患者批准以来，已经7年了; 该药可用于患者患者患者。患有高孕症被确定为要预防的显着不良事件。

著录项

来源
《Circulation journal》 |2018年第5期|共8页
作者
Kinugawa Koichiro; Sato Naoki; Inomata Takayuki; Yasuda Moriyoshi; Shibasaki Yoshiyuki; Shimakawa Toshiyuki;
展开▼
作者单位

Univ Toyama Dept Internal Med 2 2630 Sugitani Toyama 9300914 Japan;

Musashi Kosugi Hosp Div Cardiol Kawasaki Kanagawa Japan;

Kitasato Univ Kitasato Inst Hosp Dept Cardiovasc Med Tokyo Japan;

Otsuka Pharmaceut Co Ltd Tokyo Japan;

Otsuka Pharmaceut Co Ltd Tokyo Japan;

Otsuka Pharmaceut Co Ltd Tokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Aquauretic; Diuretics; Hypernatremia;

机译：水腹菌;利尿剂;高鼻血症;

相似文献

外文文献
中文文献
专利

1. Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure [J] . Koichiro Kinugawa, Naoki Sato, Takayuki Inomata, Circulation journal . 2018,第5期

机译：新的风险评分有效预防心力衰竭患者托伐普坦引起的高钠血症
2. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) [J] . Lanfear David E., Levy Wayne C., Stehlik Josef, Circulation. Heart failure . 2017,第5期

机译：西雅图心力衰竭模型和心脏病II风险评分在非孤立依赖性晚期心力衰竭患者中的准确性：路线图研究中的见解（左心室辅助设备的风险评估和对比有效性，以及动态心力衰竭患者的医学管理）
3. Inpatient Mortality Risk Scores and Postdischarge Events in Hospitalized Heart Failure Patients A Community-Based Study [J] . Win Sithu, Hussain Imad, Hebl Virginia B., Circulation. Heart failure . 2017,第7期

机译：住院治疗心力衰竭患者的住院病风险评分和后收费事件是一项社区的研究
4. Concept Design: Multi-Sensing System to Prevent Renal Deterioration in Heart Failure Patients [C] . Samah A. Atiyat, Shadi M. Karabsheh 2018 XV International Scientific Conference on Optoelectronic and Electronic Sensors . 2018

机译：概念设计：预防心力衰竭患者肾脏恶化的多传感系统
5. Blood-Pressure Reduction is Associated With Worsening in Renal Function but Does Not Prevent Successful Decongestion in Patients Treated for Acute Decompensated Heart Failure. [D] . Kula, Alexander James. 2015

机译：降压与肾功能恶化有关，但不能阻止接受急性代偿性心力衰竭治疗的患者成功消退。
6. Inpatient Mortality Risk Scores and Post-Discharge Events in Hospitalized Heart Failure Patients: A Community-Based Study [O] . Sithu Win, Imad Hussain, Virginia B. Hebl, -1

机译：住院心力衰竭患者的住院死亡率风险评分和出院后事件：一项基于社区的研究
7. Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure [O] . Koichiro Kinugawa, Naoki Sato, Takayuki Inomata, 2018

机译：新的风险评分有效地预防洛维坦诱导的心力衰竭患者的高缺失事件

Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure

摘要

著录项

相似文献

相关主题

期刊订阅